Effect of Intraoperative infusion Magnesium Sulfate Infusion on Postoperative Quality of Recovery in Patients Undergoing Total Knee Arthroplasty: A Prospective, Double-Blind, Randomized Controlled Trial
Hai Xu,Conghui Hao,Xinxin Wang,Jingjing Du,Tianyu Zhang,Xiaobao Zhang
DOI: https://doi.org/10.2147/dddt.s444896
IF: 4.3188
2024-03-26
Drug Design Development and Therapy
Abstract:Hai Xu, 1 Conghui Hao, 1 Xinxin Wang, 2 Jingjing Du, 1 Tianyu Zhang, 1 Xiaobao Zhang 2, 3 1 Department of Anesthesiology, Graduate Training Base of Lianyungang First People's Hospital of Jinzhou Medical University, Lianyungang, Jiangsu, People's Republic of China; 2 Department of Anesthesiology, The Affiliated Lianyungang Hospital of Xuzhou Medical University, Lianyungang, Jiangsu, People's Republic of China; 3 Department of Anesthesiology, The First Affiliated Hospital of Kangda College of Nanjing Medical University, Lianyungang, Jiangsu, People's Republic of China Correspondence: Xiaobao Zhang, Department of Anesthesiology, The First Affiliated Hospital of Kangda College of Nanjing Medical University, Lianyungang, Jiangsu, People's Republic of China, Email Background: Magnesium sulfate, an intravenous adjuvant, has recently attracted immense attention in multimodal analgesia. Previous studies confirmed the crucial role of magnesium sulfate in postoperative pain and nociceptive hypersensitivity. However, the effect of magnesium sulfate in multimodal analgesia on the quality of recovery (QoR) for elderly patients has not been thoroughly studied. Therefore, the present experiment aimed to investigate the effect of continuous intravenous magnesium sulfate on the quality of postoperative recovery in elderly patients undergoing total knee arthroplasty (TKA). Patients and Methods: In this study, a total of 148 patients scheduled to undergo unilateral total knee arthroplasty were randomized into a magnesium sulfate group (Group M, n=68) and a control group (Group C, n=66) using a double-blind, randomized controlled trial. Before induction of anesthesia, Group M received intravenous magnesium sulfate (40 mg/kg) for 15 min, followed by a continuous infusion (15 mg/kg) until the end of the procedure. In the same manner, Group C received an infusion of the same amount of isotonic saline using the same method as the Group M. Results: Compared with Group C, Group M had significantly better QoR-15 scores on postoperative day 1(POD 1 ) than Group C ( P < 0.05). Analysis of the dimensions of QoR-15 scores indicated that Group M exhibited notably reduced levels of pain, and higher levels of emotional state and physical comfort than Group C ( P < 0.05). Furthermore, Group C had significantly higher numerical rating scale (NRS) scores at POD 1 than Group M ( P < 0.05). Conclusion: For elderly patients undergoing knee arthroplasty, magnesium sulfate can be used as an adjuvant in a multimodal analgesic regimen to reduce early postoperative pain and improve the quality of early postoperative recovery. Keywords: magnesium sulfate, quality of recovery, postoperative pain, multimodal analgesic regimen, total knee arthroplasty In recent years, there has been an increasing focus on enhancing postoperative recovery to improve the quality of life for patients and facilitate their return to normal life functions. Especially in geriatric patients, total knee arthroplasty (TKA) is one of the most prevalent orthopedic procedures. During the initial postoperative phase following TKA, an estimated 60% of patients experience severe pain while 30% endure moderate pain, 1 which dramatically reduces the quality of recovery (QoR), extends the duration of hospitalization and functional immobility and increases the risk of postoperative complications. 2–5 To enhance recovery after surgery (ERAS), enhancing the quality of recovery and a more favorable recovery experience mitigates complications and alleviates patient anxiety. 6 Historically, opioids have been used as the first-line medication for postoperative analgesia following TKA. However, they may impede early postoperative recovery and diminish the quality of life of patients due to various adverse effects. Consequently, anesthesiologists are facing the challenge of minimizing intraoperative and postoperative opioid use while establishing an efficient strategy for pain management. It is important to note that opioids continue to play an essential role in the multimodal analgesia regimen for perioperative pain management. We aspire to achieve our vision of exploring different approaches in order to establish multimodal analgesic strategies. Magnesium sulfate exerts antinociceptive effects by blocking N-methyl-D-aspartate (NMDA) receptors and related ion channels. It has been proposed as a potential adjunct to multimodal analgesic regimens. A continuous intraoperative infusion of magnesium sulfate can reduce postoperative pain, suppress nociceptive sensitization to some extent, and reduce the use of opioids. 7–9 However -Abstract Truncated-
pharmacology & pharmacy,chemistry, medicinal